COVID-19 vaccine

May 5, 2022

COVID-associated bleeding risk

While case reports have noted acquired hemophilia after COVID-19 infection or vaccination, a new study finds no increased risk.

By Leigh MacMillan
April 25, 2022

VUMC offers second booster to eligible individuals

By VUMC News and Communications
April 13, 2022

Additional COVID vaccine helps protect transplant patients

Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows.

By Nancy Humphrey
April 13, 2022

Volunteering for vaccine research a family affair

By Kristin Smart
April 7, 2022

Study explores parents’ reluctance to flu, COVID vaccines for children

Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.

By Jessica Pasley
Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.
March 7, 2022

Teen shares his battle with MIS-C following COVID-19 infection

Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children’s Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.

By Christina Echegaray
March 3, 2022

COVID-19: two years of challenges, lessons, victories

Two years ago this week, the cataclysmic coronavirus known as SARS-CoV-2 arrived in Middle Tennessee.
By Bill Snyder
February 24, 2022

MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis

A Vanderbiltl study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C).
By Kylie Avery
February 9, 2022

Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization

Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.
By Kristin Smart
January 24, 2022

Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines

Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.
By Jessica Pasley
December 2, 2021

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

By Bill Snyder
November 23, 2021

VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit

Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C.
By Bill Snyder
November 15, 2021

Common questions about COVID vaccine and pregnancy

By Nancy Humphrey
1 2 3 4 5